Pharma Innovation Faces New Challenges And Presents New Solutions In 2015
The top players in the pharmaceutical industry are heading to the 33rd Annual J.P. Morgan Healthcare Conference this week to revisit the many successes of 2014, and to better understand what challenges and opportunities the industry will face in 2015. Although budgets are shrinking, the changing healthcare landscape presents many opportunities to further develop innovative medicines for patients.
Moving forward in 2015, Astellas is focused on developing innovative medicines for patients by embracing open innovation with academia, government agencies and other biopharmaceutical companies, and by reshaping R&D to concentrate our efforts on the best science and best talent in a new era of precision medicine.
Click here to read about the Company’s participation in the J.P. Morgan Healthcare Conference.
Astellas US LLC, located in Northbrook, Illinois is an affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us or follow us on Twitter at @AstellasUS.
For further information: Jenny Kite, 224-205-5405, Jenny.Kite@Astellas.com